| Year |
Citation |
Score |
| 2023 |
Wang Y, Yeatts SD, Martin RH, Silbergleit R, Rockswold GL, Barsan WG, Korley FK, Rockswold S, Gajewski BJ. Selection of a statistical analysis method for the Glasgow Outcome Scale-Extended endpoint for estimating the probability of favorable outcome in future severe TBI clinical trials. Statistics in Medicine. PMID 37599009 DOI: 10.1002/sim.9877 |
0.41 |
|
| 2023 |
Harder TJ, Leary OP, Yang Z, Lucke-Wold B, Liu DD, Still MEH, Zhang M, Yeatts SD, Allen JW, Wright D, Merck D, Merck LH. Early Signs of Elevated Intracranial Pressure (ICP) on Computed Tomography Correlate with Measured ICP in the Intensive Care Unit and Six-Month Outcome Following Moderate to Severe TBI. Journal of Neurotrauma. PMID 37082956 DOI: 10.1089/neu.2022.0433 |
0.715 |
|
| 2022 |
Bantis LE, Young KJ, Tsimikas JV, Mosier BR, Gajewski B, Yeatts S, Martin RL, Barsan W, Silbergleit R, Rockswold G, Korley FK. Statistical assessment of the prognostic and the predictive value of biomarkers-A biomarker assessment framework with applications to traumatic brain injury biomarker studies. Research Methods in Medicine & Health Sciences. 4: 34-48. PMID 37009524 DOI: 10.1177/26320843221141056 |
0.491 |
|
| 2022 |
Mainali S, Cardim D, Sarwal A, Merck LH, Yeatts SD, Czosnyka M, Shutter L. Prolonged Automated Robotic TCD Monitoring in Acute Severe TBI: Study Design and Rationale. Neurocritical Care. PMID 35381966 DOI: 10.1007/s12028-022-01483-6 |
0.648 |
|
| 2022 |
Foster L, Robinson L, Yeatts SD, Conwit RA, Shehadah A, Lioutas V, Selim M. Effect of Deferoxamine on Trajectory of Recovery After Intracerebral Hemorrhage: A Post Hoc Analysis of the i-DEF Trial. Stroke. STROKEAHA121037298. PMID 35306827 DOI: 10.1161/STROKEAHA.121.037298 |
0.334 |
|
| 2022 |
Bernard F, Barsan W, Diaz-Arrastia R, Merck LH, Yeatts S, Shutter LA. Brain Oxygen Optimization in Severe Traumatic Brain Injury (BOOST-3): a multicentre, randomised, blinded-endpoint, comparative effectiveness study of brain tissue oxygen and intracranial pressure monitoring versus intracranial pressure alone. Bmj Open. 12: e060188. PMID 35273066 DOI: 10.1136/bmjopen-2021-060188 |
0.694 |
|
| 2022 |
Muehlschlegel S, Perman SM, Elmer J, Haggins A, Teixeira Bailey ND, Huang J, Jansky L, Kirchner J, Kasperek-Wynn R, Lipman PD, Yeatts SD, Fetters MD, Dickert NW, Silbergleit R. The Experiences and Needs of Families of Comatose Patients After Cardiac Arrest and Severe Neurotrauma: The Perspectives of National Key Stakeholders During a National Institutes of Health-Funded Workshop. Critical Care Explorations. 4: e0648. PMID 35265851 DOI: 10.1097/CCE.0000000000000648 |
0.347 |
|
| 2021 |
Wei C, Wang J, Foster LD, Yeatts SD, Moy C, Mocco J, Selim M. Effect of Deferoxamine on Outcome According to Baseline Hematoma Volume: A Post Hoc Analysis of the i-DEF Trial. Stroke. STROKEAHA121035421. PMID 34789008 DOI: 10.1161/STROKEAHA.121.035421 |
0.341 |
|
| 2020 |
Korley FK, Pauls Q, Yeatts SD, Jones C, Corbett-Valade E, Silbergleit R, Frankel M, Barsan WG, Cahill N, Bazarian J, Wright D. Progesterone treatment does not decrease serum levels of biomarkers of glial and neuronal cell injury in moderate and severe TBI subjects: A secondary analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III trial. Journal of Neurotrauma. PMID 33319651 DOI: 10.1089/neu.2020.7072 |
0.506 |
|
| 2020 |
Leary OP, Merck LH, Yeatts SD, Pan I, Liu DD, Harder TJ, Jung S, Collins S, Braileanu M, Gokaslan ZL, Allen JW, Wright D, Merck D. Computer-Assisted Measurement of Traumatic Brain Hemorrhage Volume is More Predictive of Functional Outcome and Mortality than Standard ABC/2 Method: An Analysis of CT Imaging Data from the ProTECTIII Trial. Journal of Neurotrauma. PMID 33191851 DOI: 10.1089/neu.2020.7209 |
0.673 |
|
| 2020 |
Yeatts SD, Martin RH, Meurer W, Silbergleit R, Rockswold G, Barsan WG, Korley FK, Wright D, Gajewski BJ. Sliding Scoring of the Glasgow Outcome Scale - Extended (GOS-E) as Primary Outcome in Traumatic Brain Injury Trials. Journal of Neurotrauma. PMID 32664792 DOI: 10.1089/Neu.2019.6969 |
0.413 |
|
| 2019 |
Frankel M, Fan L, Yeatts SD, Jeromin A, Vos PE, Wagner AK, Wolf BJ, Pauls Q, Lunney M, Merck LH, Hall CL, Palesch Y, Silbergleit R, David W. The Association of Very Early Serum levels of S100B, GFAP, UCH-L1, and SBDP with Outcome in ProTECT III. Journal of Neurotrauma. PMID 30794101 DOI: 10.1089/Neu.2018.5809 |
0.703 |
|
| 2019 |
Merck LH, Yeatts SD, Silbergleit R, Manley GT, Pauls Q, Palesch Y, Conwit R, Le Roux P, Miller J, Frankel M, Wright DW. The Effect of Goal-Directed Therapy on Patient Morbidity and Mortality After Traumatic Brain Injury, Results From the Progesterone for the Treatment of Traumatic Brain Injury III Clinical Trial. Critical Care Medicine. PMID 30730438 DOI: 10.1097/Ccm.0000000000003680 |
0.726 |
|
| 2018 |
Nuño T, Denninghoff KR, Pauls Q, Yeatts SD, Silbergleit R, Palesch YY, Merck LH, Manley G, Wright DW. Reply to: Prehospital Intubation: Further Confounders in Trial Results. Prehospital Emergency Care : Official Journal of the National Association of Ems Physicians and the National Association of State Ems Directors. 1. PMID 29338483 DOI: 10.1080/10903127.2017.1408729 |
0.611 |
|
| 2017 |
Denninghoff KR, Nuño T, Pauls Q, Yeatts SD, Silbergleit R, Palesch YY, Merck LH, Manley GT, Wright DW. Prehospital Intubation is Associated with Favorable Outcomes and Lower Mortality in ProTECT III. Prehospital Emergency Care : Official Journal of the National Association of Ems Physicians and the National Association of State Ems Directors. 1-6. PMID 28489506 DOI: 10.1080/10903127.2017.1315201 |
0.718 |
|
| 2017 |
Venema E, Mulder MJHL, Roozenbeek B, Broderick JP, Yeatts SD, Khatri P, Berkhemer OA, Emmer BJ, Roos YBWEM, Majoie CBLM, van Oostenbrugge RJ, van Zwam WH, van der Lugt A, Steyerberg EW, Dippel DWJ, et al. Selection of patients for intra-arterial treatment for acute ischaemic stroke: development and validation of a clinical decision tool in two randomised trials. Bmj (Clinical Research Ed.). 357: j1710. PMID 28468840 DOI: 10.1136/Bmj.J1710 |
0.326 |
|
| 2016 |
Goldstein FC, Caveney A, Hertzberg VS, Silbergleit R, Yeatts S, Palesch Y, Levin H, David W. Very Early Administration of Progesterone Does Not Improve Neuropsychological Outcomes in Subjects with Moderate to Severe TBI. Journal of Neurotrauma. PMID 26973025 DOI: 10.1089/Neu.2015.4313 |
0.336 |
|
| 2015 |
Wright DW, Yeatts SD, Silbergleit R. Progesterone in traumatic brain injury. The New England Journal of Medicine. 372: 1766-7. PMID 25923558 DOI: 10.1056/NEJMc1503138 |
0.457 |
|
| 2014 |
Wright DW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M, Goldstein FC, Caveney AF, Howlett-Smith H, Bengelink EM, Manley GT, Merck LH, Janis LS, Barsan WG. Very early administration of progesterone for acute traumatic brain injury. The New England Journal of Medicine. 371: 2457-66. PMID 25493974 DOI: 10.1056/Nejmoa1404304 |
0.723 |
|
| 2014 |
Khatri P, Yeatts SD, Mazighi M, Broderick JP, Liebeskind DS, Demchuk AM, Amarenco P, Carrozzella J, Spilker J, Foster LD, Goyal M, Hill MD, Palesch YY, Jauch EC, Haley EC, et al. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. The Lancet. Neurology. 13: 567-74. PMID 24784550 DOI: 10.1016/S1474-4422(14)70066-3 |
0.315 |
|
| 2013 |
Garofolo KM, Yeatts SD, Ramakrishnan V, Jauch EC, Johnston KC, Durkalski VL. The effect of covariate adjustment for baseline severity in acute stroke clinical trials with responder analysis outcomes. Trials. 14: 98. PMID 24499406 DOI: 10.1186/1745-6215-14-98 |
0.305 |
|
| Show low-probability matches. |